Constarium
← Search

Omics · study · 2026

DNMT1 Facilitates the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease [RNA-seq]

Listed in NCBI GEO

Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by notable epigenetic changes, such as alterations in DNA methylation.

Description

However, research on epigenetic modifications in human patient and animal models remains sparse. This study investigates the role of DNMT1 in MASLD progression.

DNMT1 inhibition restores DNA methylation patterns and transcriptional activity, suggesting it as a potential therapeutic target for MASLD.

Links

Topics

From keywords
Life Sciences
Inferred from text
Disease 75% · RNA sequencing 65%
Provenance · 1 source records, 9 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE28444610 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:diseaseenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[organism].NCBITaxon:10090source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title